CD3E and melanoma: The markers utilized in the conducted study, as defined by Tirosh and colleagues, successfully differentiated between various cell types [23, 39], including melanoma cell (MLANA, PMEL), T cell (CD2, CD3D, CD3E, CD4, CD8A).